Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Novoste (novt) -- Ignore unavailable to you. Want to Upgrade?

To: vaipor who wrote (89)	1/11/2001 7:13:53 PM
From: Oak Tree	Read Replies (1) \| Respond to of 100

First off, laboratory experiments have tried chemo to prevent restenosis for years. Some of this is reviewed in this article. ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10418707&dopt=Abstract Second, there are no positive clinical trials for chemo stents, and every one of the radiation trials was very positive. (There are at least 4 now) ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11132163&dopt=Abstract Finally, a recent book now in its second addition edited by Ron Waksman ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11060820&dopt=Abstract I stick with my original statement that chemo stents will not work nearly as well if at all compared to radiation. The problem with radiation is the cost of the disposable catheter. That will kill the procedure unless payments can be increased (unlikely) or the catheter can be avoided (that can be done since the first study used no special catheter).